ClinicalTrials.gg

Gilead Sciences: Lymphoma, B-Cell, Marginal Zone trials

The registry lists 11 Lymphoma, B-Cell, Marginal Zone studies with Gilead Sciences as lead sponsor. 0 are open to participants now and 6 have results posted.

Phase 1 5Phase 2 5Phase 3 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.